Dr. Hunter outlines anemia treatment options for myelofibrosis patients
Dr. Anthony M. Hunter, a hematology specialist, discussed how clinicians approach anemia in patients with myelofibrosis.
He highlighted luspatercept as one therapeutic option, noting its mechanism and where it fits in treatment sequencing, while also mentioning alternative agents such as erythropoiesis‑stimulating agents and supportive care measures.
The conversation emphasized individualized decision‑making based on disease severity, patient comorbidities, and response to prior therapies, underscoring the need for careful assessment when selecting anemia management strategies.
This writeup was produced by pharmadog from original reporting by onclive. The original article may no longer be reachable at its published URL.
Original headline: “Dr Hunter on Luspatercept and Other Treatment Options for Anemia in Myelofibrosis”
read at onclive ↗
comments(0)
5-min edit window · permanent after that